CLINICAL_TRIALS
research
· 2017-07-21
Clinical Trial Update: The Randomized Controlled Clinical Trial of Kushen Injection [Phase 4]
Summary
Update on a Phase 4 randomized controlled trial evaluating Kushen Injection for lung cancer; current status is UNKNOWN.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beijing Zheng Ju Medical Technology Co., Ltd. | Conditions: Lung Cancer | Phase 4 | Status: UNKNOWN